Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019: CHEST Guideline and Expert Panel Report - PubMed (original) (raw)
Practice Guideline
Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019: CHEST Guideline and Expert Panel Report
Lisa K Moores et al. Chest. 2020 Sep.
Abstract
Background: Emerging evidence shows that severe coronavirus disease 2019 (COVID-19) can be complicated by a significant coagulopathy, that likely manifests in the form of both microthrombosis and VTE. This recognition has led to the urgent need for practical guidance regarding prevention, diagnosis, and treatment of VTE.
Methods: A group of approved panelists developed key clinical questions by using the PICO (Population, Intervention, Comparator, Outcome) format that addressed urgent clinical questions regarding the prevention, diagnosis, and treatment of VTE in patients with COVID-19. MEDLINE (via PubMed or Ovid), Embase, and Cochrane Controlled Register of Trials were systematically searched for relevant literature, and references were screened for inclusion. Validated evaluation tools were used to grade the level of evidence to support each recommendation. When evidence did not exist, guidance was developed based on consensus using the modified Delphi process.
Results: The systematic review and critical analysis of the literature based on 13 Population, Intervention, Comparator, Outcome questions resulted in 22 statements. Very little evidence exists in the COVID-19 population. The panel thus used expert consensus and existing evidence-based guidelines to craft the guidance statements.
Conclusions: The evidence on the optimal strategies to prevent, diagnose, and treat VTE in patients with COVID-19 is sparse but rapidly evolving.
Keywords: COVID-19; DIC; DVT; VTE; hypercoagulability; pulmonary embolism.
Published by Elsevier Inc.
Similar articles
- The Use of Bronchoscopy During the Coronavirus Disease 2019 Pandemic: CHEST/AABIP Guideline and Expert Panel Report.
Wahidi MM, Shojaee S, Lamb CR, Ost D, Maldonado F, Eapen G, Caroff DA, Stevens MP, Ouellette DR, Lilly C, Gardner DD, Glisinski K, Pennington K, Alalawi R. Wahidi MM, et al. Chest. 2020 Sep;158(3):1268-1281. doi: 10.1016/j.chest.2020.04.036. Epub 2020 May 1. Chest. 2020. PMID: 32361152 Free PMC article. - The management of venous thromboembolism in hospitalized patients with COVID-19.
Spyropoulos AC. Spyropoulos AC. Blood Adv. 2020 Aug 25;4(16):4028. doi: 10.1182/bloodadvances.2020002496. Blood Adv. 2020. PMID: 32841342 Free PMC article. Review. - Antithrombotic Therapy in Arterial Thrombosis and Thromboembolism in COVID-19: An American College of Chest Physicians Expert Panel Report.
Potpara T, Angiolillo DJ, Bikdeli B, Capodanno D, Cole O, Yataco AC, Dan GA, Harrison S, Iaccarino JM, Moores LK, Ntaios G, Lip GYH. Potpara T, et al. Chest. 2023 Dec;164(6):1531-1550. doi: 10.1016/j.chest.2023.06.032. Epub 2023 Jun 29. Chest. 2023. PMID: 37392958 - Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines.
Zhai Z, Li C, Chen Y, Gerotziafas G, Zhang Z, Wan J, Liu P, Elalamy I, Wang C; Prevention Treatment of VTE Associated with COVID-19 Infection Consensus Statement Group. Zhai Z, et al. Thromb Haemost. 2020 Jun;120(6):937-948. doi: 10.1055/s-0040-1710019. Epub 2020 Apr 21. Thromb Haemost. 2020. PMID: 32316065 Free PMC article. Review. - Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines.
Fontana P, Casini A, Robert-Ebadi H, Glauser F, Righini M, Blondon M. Fontana P, et al. Swiss Med Wkly. 2020 Jun 21;150:w20301. doi: 10.4414/smw.2020.20301. eCollection 2020 Jun 15. Swiss Med Wkly. 2020. PMID: 32640479
Cited by
- Alteplase in COVID-19 severe hypoxemic respiratory failure: the TRISTARDS multicenter randomized trial.
Landoni G, Chowdary P, Meziani F, Creteur J, De Schryver N, Motsch J, Henrichmoeller I, Pagès A, Peter N, Danays T, Weigand MA; TRISTARDS Investigators. Landoni G, et al. Ann Intensive Care. 2024 Nov 10;14(1):170. doi: 10.1186/s13613-024-01386-z. Ann Intensive Care. 2024. PMID: 39522090 Free PMC article. - Cardiovascular disease and covid-19: A systematic review.
Krishna BA, Metaxaki M, Sithole N, Landín P, Martín P, Salinas-Botrán A. Krishna BA, et al. Int J Cardiol Heart Vasc. 2024 Aug 2;54:101482. doi: 10.1016/j.ijcha.2024.101482. eCollection 2024 Oct. Int J Cardiol Heart Vasc. 2024. PMID: 39189008 Free PMC article. Review. - Symptomatic Venous Thromboembolic Events in COVID-19 Patients after Hospital Discharge: Aspects to Consider.
Pop C, Hermenean A, Moș L, Cotoraci C. Pop C, et al. Rev Cardiovasc Med. 2022 Jun 20;23(6):219. doi: 10.31083/j.rcm2306219. eCollection 2022 Jun. Rev Cardiovasc Med. 2022. PMID: 39077187 Free PMC article. Review. - Guidance for clinical practice using emergency and point-of-care ultrasonography.
Kameda T, Ishii H, Oya S, Katabami K, Kodama T, Sera M, Takei H, Taniguchi H, Nakao S, Funakoshi H, Yamaga S, Senoo S, Kimura A. Kameda T, et al. Acute Med Surg. 2024 Jun 26;11(1):e974. doi: 10.1002/ams2.974. eCollection 2024 Jan-Dec. Acute Med Surg. 2024. PMID: 38933992 Free PMC article. Review. - Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study.
Jara-Palomares L, Bikdeli B, Jiménez D, Muriel A, Demelo-Rodríguez P, Moustafa F, Villalobos A, López-Miguel P, López-Jiménez L, Otálora S, Peris ML, Amado C, Chopard R, Rivera-Cívico F, Monreal M; RIETE Investigators. Jara-Palomares L, et al. EClinicalMedicine. 2024 May 25;73:102659. doi: 10.1016/j.eclinm.2024.102659. eCollection 2024 Jul. EClinicalMedicine. 2024. PMID: 38828131 Free PMC article.
References
- Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19 [published online ahead of print April 18, 2020]. Am J Emerg Med.https://doi.org/10.1016/j.ajem.2020.04.048. - DOI - PMC - PubMed